Latest Breaking News On - Oreola donini - Page 2 : comparemela.com

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.

United statesAxel lehrerOreola doniniOur public health solutionsUs congressExchange commissionSoligenix incDrug administrationDefense threat reduction agencyNational institute of allergyCenters for diseaseBiomedical advanced researchPrnewswire soligenix incDevelopment authorityUniversity of hawaiProvides suvax

Baystreet ca - Solinex Down on Orphan Drug Designation

Soligenix, Inc. (NASDAQ: SNGX) saw its stock prices slightly off early Thursday. The Princeton, New Jersey-based company, a late-stage biopharmaceutical concern focused on developing and commercializing products to treat rare diseases where there is .

United statesOreola doniniDrug administrationSoligenix incNew jersey basedOrphan products developmentDrug actBiologics license applicationChief scientific officer oreola donini

Sudan Ebola Virus Vaccine Candidate Gets Orphan Drug Status

SuVax is a subunit protein vaccine of recombinantly expressed Sudan ebolavirus glycoprotein.

Oreola doniniDrug administrationOrphan drugSenior vice presidentChief scientific officer

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses

Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses PRINCETON, N.J., Jan. 2, 2024 /PRNewswire/ Soligenix, Inc. , a late-stage.

United statesUniversity of hawaii at manoaAxel lehrerOreola doniniPrnewswire soligenix incDepartment of tropical medicineCompany public health solutionsUs developmentOur public health solutionsNational institute of allergySoligenix incSmall business innovation researchUs congressUniversity of hawaiJohna burns school of medicineBiomedical advanced research

Soligenix (SNGX) Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses

Soligenix (SNGX) Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Oreola doniniAxel lehrerSoligenix incSmall business innovation researchJohna burns school of medicineUniversity of hawaiCompany public health solutionsNational institute of healthDepartment of tropical medicineAssociate professorTropical medicineMedical microbiologySenior vice presidentChief scientific officerPublic health solutionsNational institute